Nanalysis Scientific Corp.NSCI.V

Information Technology · Technology Hardware & Equipment · TSX-V · Canada · nanalysis.com

Nanalysis Scientific Corp. develops, manufactures, and sells compact Nuclear Magnetic Resonance (NMR) spectrometers and Magnetic Resonance Imaging (MRI) systems for pharmaceutical, biotech, chemical, food, security, and life science applications globally. The company operates through Scientific Equipment and Security Services segments, offering the 60-NMR, 100-NMR, and other magnetic resonance platforms from its base in Calgary, Alberta.

Key ratios

Operating cash flow growth

5.8%TTM

2025 5.8%

FCF / Sales

7.9%TTM

2025 7.9%2024 7.0%2023 -41.9%

Net margin

-14.1%TTM

2025 -14.1%2024 -29.9%2023 -56.9%

ROA

-5.8%TTM

2025 -5.8%2024 -4.5%2023 -13.6%

ROE

-39.1%TTM

2025 -39.1%2024 -69.8%2023 -47.2%

Revenue growth

-11.8%TTM

2025 -11.8%2024 59.8%2023 14.7%

Recent news

Nanalysis Announces Second Quarter 2026 Results 2026-08-24 · CNW Nanalysis Announces Second Quarter 2026 Conference Call 2026-08-18 · CNW Nanalysis Announces Grant of Options and Restricted Share Units 2026-07-03 · Newswire (CNW)Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities 2026-06-23 · PR Newswire Nanalysis Announces First Quarter 2026 Results 2026-05-20 · PR Newswire

Track NSCI.V in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer